ABCG2 and cancer: Several potential mechanisms underlying MDR have been identified in cancer cells, including reduced drug uptake, increased drug efflux by the ABC transporter family, regulation by cancer stem cells, altered DNA damage response and repair, induction of hypoxia, altered drug targets and sequestration of anticancer drugs in intracellular organelles[61-67].